*0012812950
*00520250916095124.0
*007ta
*008250916s2025    no d     m    00  0 eng c
*00902816nam a2200469 c 4500
*019  $bl
*020  $a9788234806612$qheftet
*035  $a(EXLNZ-47BIBSYS_NETWORK)999922914400202201
*035  $a(NO-DIMO)acf7ea2f-7a23-4e39-ab3a-17e7c0e4aafd
*035  $a(NO-LaBS)51910402(bibid)
*035  $aoai:nb.no:pliktmonografi_000053711
*035  $aoai:nb.no:pliktmonografi_000053711
*040  $aNO-TrBIB$bnob$erda
*041  $aeng$beng$bnob
*060 4$aQZ 380
*1001 $aBlakstad, Hanne Kristin Jahr$0(NO-TrBIB)1755667232731$4aut$_397107500
*24000$aGlioblastoma$_397107600
*24510$aGlioblastoma :$btreatment, outcome, and prognostic factors$cHanne Kristin Jahr Blakstad
*264 1$aOslo$bInstitute of Clinical Medicine, Faculty of Medicine, University of Oslo$c2025
*300  $a1 bind (varierende paginering)$bfigurer
*336  $atekst$0http://rdaregistry.info/termList/RDAContentType/1020$2rdaco
*337  $auformidlet$0http://rdaregistry.info/termList/RDAMediaType/1007$2rdamt
*338  $abind$0http://rdaregistry.info/termList/RDACarrierType/1049$2rdact
*4901 $aSeries of dissertations submitted to the Faculty of Medicine, University of Oslo
*500  $aDelvis opptrykk av artikler
*500  $aDelvis opptrykk av artikler
*502  $aAvhandling (Ph.D) - Universitetet i Oslo, 2025
*520  $aThis academic thesis explores glioblastoma, a highly aggressive form of brain cancer, focusing on its treatment, patient outcomes, and prognostic factors. The study delves into the challenges of managing glioblastoma, evaluates therapeutic approaches, and examines factors influencing prognosis. Conducted within the framework of the Institute of Clinical Medicine at the University of Oslo and the Oslo University Hospital, the research contributes to the field of oncology by providing insights into improving patient care and advancing treatment strategies.$7Generated by AI
*546  $aEngelsk tekst, sammendrag på engelsk og norsk
*588  $aPart of the metadata in this record was created with the help of AI Metadata Assistant
*650 0$aCancer$xPrognosis$_397107700
*650 0$aMedical sciences$xNorway$_397107800
*650 0$aOncology$xResearch$_397107900
*650 2$aBrain Neoplasms$xdrug therapy$0(DNLM)D001932Q000188$_397108000
*650 2$aBrain Neoplasms$xtherapy$0(DNLM)D001932Q000628$_92047100
*650 2$aGlioblastoma$xdrug therapy$0(DNLM)D005909Q000188$_397108100
*650 2$aGlioblastoma$xtherapy$0(DNLM)D005909Q000628$_12926200
*650 2$aTime-to-Treatment$xstatistics & numerical data$0(DNLM)D061665Q000706$_397108200
*655 7$aDoktoravhandlinger$0(uri)https://id.nb.no/vocabulary/ntsf/61$2ntsf$_202811400
*655 7$aDoktoravhandlinger$0https://id.nb.no/vocabulary/ntsf/61$2ntsf$_10604600
*7001 $aBlakstad, Hanne Kristin Jahr$0(NO-TrBIB)1755667232731$tGlioblastoma$_397107500
*7102 $aUniversitetet i Oslo$bDet medisinske fakultet$0(NO-TrBIB)90302138$4pbl$_10213300
*7102 $aUniversitetet i Oslo$bInstitutt for klinisk medisin$0(NO-TrBIB)15000758$4dgg$_10213400
*830 0$aSeries of dissertations submitted to the Faculty of Medicine, University of Oslo$_10213500
*85640$uhttps://urn.nb.no/URN:NBN:no-nb_pliktmonografi_000053711$3Fulltekst$yNettbiblioteket$zDigital representasjon
*917  $ad
*999  $aoai:nb.bibsys.no:999920650564202202$b2025-09-18T00:03:21Z$z999920650564202202
^